Establishment of doxorubicin-resistant human bladder cancer cell line (BIU-87/ADMR) and its mechanism of multidrug resistance

Chinese Medical Journal

Volumn 110, Issue 3, 1997, Pages 167-172

  Guo, Heqing ^a   Lu, Gongcheng ^a   Xiong, Xulin ^a   Dong, Jihua ^a   Liu, Shaochun ^a   Zhao, Shiyu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; MITOMYCIN C; VINCRISTINE;

ARTICLE; BLADDER CANCER; CANCER CELL; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE;

CARCINOMA, TRANSITIONAL CELL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHENOTYPE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0030914532     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mosco JA, Cowan KH. Multidrug resistance. J Natl Cancer Inst 1988; 80:14.
2. Johnson R, Chitnis MP, Embrey WM, et al. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep 1978; 62:1535.
3. Tsuruo T, Lida-saito H, Kawabata H, et al. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn J Cancer Res (Gann) 1986; 77:682.
4. McGrath T, Latoud C, Arnold ST, et al. Mechanisms of multidrug resistane in HL60 cells: analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 1989; 38:3611.
5. McGovern F, Kachel T, Vijan S, et al. Establishment and characterization of a doxorubicin human bladder cancer cell line (MGH-U1R). J Urol 1988; 140:410.
6. Shinohara N, Liebert M, Wedemeyer G, et al. Evaluation of multiple drug resistance in human bladder cancer cell lines. J Urol 1993; 150:505.
7. Lin CW, Lin JC, Prout GR. Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy. Cancer Res 1985; 45:5070.
8. Yu L, Huang Y, Yiang C, et al. Establishment of epithelial cell line BIU-87 from a human bladder transitional cell carcinoma and its biological characteristics. Chin J Urol 1989; 10:131.
9. Sargent JM, Taylor CG. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukemia. Br J Cancer 1989; 60:206.
10. Hongo T, Fujii Y, Igarashi Y. An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 1990; 65:1263.
11. Howell N, Belli TA, Zaczkiewicz LT, et al. High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes. Cancer Res 1984; 44:4023.
12. Harker WG, Sikic BI. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res 1985; 45:4091.
13. Keizer HG, Schuurhuis G, Broxterman HJ, et al. Correlation of multidrug resistance with decreased drug accumulation, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells. Cancer Res 1989; 49:2988.
14. Scheper RJ, Bulte JWM, Brakkee JGP, et al. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance. Int J Cancer 1988; 42:389.
15. Goldstein LJ, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81:116.
16. Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258:1650.
17. Grant CE, Valdimarsson G, Hipfner DR, et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drug. Cancer Res 1994; 54:357.
18. Zhu Q, Center MS. Cloning and sequence analysis of the promoter region of the MRP gene of HL 60 cells isolated for resistance to adriamycin. Cancer Res 1994; 54:4488.
19. Mungikar A, Chitnis M, Gothoskar B. Mixed-function oxidase enzymes in adriamycin-sensitive and resistant sublines of P388 leukemia. Chem Biol Interact 1981; 35:119.
20. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54:4313.
21. Sikic BI. Modulation of multidrug resistance: at the threshold. J Clin Oncol 1993; 11:1629.
22. Lum BL, Fisher GA, Brophy NA, et al. Clinical trials of modulation of multidrug resistance. Cancer 1993s 72(Suppl):3502.